MaveriX Oncology Competitors and Similar CompaniesClear all
Avectas's competitors and similar companies include Immunicom and Nuvectis Pharma.
 Avectas Avectas is a company developing a non-viral cell engineering technology which efficiently engineers therapeutic cells, at scale, while maintaining optimal cell functionality. |  Immunicom Immunicom is a company that develops and commercializes a non-drug-based cancer therapy in order to reduce treatment side effects and enhance its response rates. |  Nuvectis Pharma Nuvectis Pharma (formerly known as Centry Pharma) is a biopharmaceutical company focused on precision medicines for cancer treatment. | |
Founding Date | Founding Date 2010 | Founding Date 2013 | Founding Date 2020 |
Type | Type Private | Type Private | Type Public |
Tags | |||
Locations | Locations Kildare, IE HQ Cambridge, US | Locations San Diego, US HQ | Locations Fort Lee, US HQ |
Employees | Employees 40 | Employees 22 | Employees 6 |
Funding | |||
Latest funding round | Latest funding round $ 20m (about 6 years ago) | Latest funding round $ 1.9m (over 6 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 32.6m | Total funding raised $ 21.9m | Total funding raised $ 15.3m |
For sources of this data, please see the company profile
View Company Profiles
Immunicom
HQ
San Diego, US
Employees
22
Immunicom is a company that develops and commercializes a non-drug-based cancer therapy in order to reduce treatment side effects and enhance its response rates.
View companyNuvectis Pharma
HQ
Fort Lee, US
Employees
6
Nuvectis Pharma (formerly known as Centry Pharma) is a biopharmaceutical company focused on precision medicines for cancer treatment.
View company